Pancreatic cancer physical examination: Difference between revisions
No edit summary |
|||
| Line 37: | Line 37: | ||
==References== | ==References== | ||
{{ | {{Reflist|2}} | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
Revision as of 18:57, 28 August 2012
|
Pancreatic cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Pancreatic cancer physical examination On the Web |
|
American Roentgen Ray Society Images of Pancreatic cancer physical examination |
|
Risk calculators and risk factors for Pancreatic cancer physical examination |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]
Overview
During physical examination, a clinician may find characteristics of pancreatic cancer in a patient. These include: pain,. weight loss, or jaundice.
Physical Examination
Most patients with pancreatic cancer experience pain, weight loss, or jaundice.[1]
Pain is present in 80 to 85 percent of patients with locally advanced or advanced metastic disease. The pain is usually felt in the upper abdomen as a dull ache that radiates straight through to the back. It may be intermittent and made worse by eating. Weight loss can be profound; it can be associated with anorexia, early satiety, diarrhea, or steatorrhea. Jaundice is often accompanied by pruritus and dark urine. Painful jaundice is present in approximately one-half of patients with locally unresectable disease, while painless jaundice is present in approximately one-half of patients with a potentially resectable and curable lesion.
The initial presentation varies according to location of the cancer. Malignancies in the pancreatic body or tail usually present with pain and weight loss, while those in the head of the gland typically present with steatorrhea, weight loss, and jaundice. The recent onset of atypical diabetes mellitus, a history of recent but unexplained thrombophlebitis (Trousseau's sign), or a previous attack of pancreatitis are sometimes noted.
Courvoisier sign defines the presence of jaundice and a painlessly distended gallbladder as strongly indicative of pancreatic cancer, and may be used to distinguish pancreatic cancer from gallstones.
Tiredness, irritability and difficulty eating due to pain also exist. Pancreatic cancer is usually discovered during the course of the evaluation of aforementioned symptoms.
Recent research indicates that in pancreatic cancer malignancies, the tumor contains markedly higher levels of certain microRNAs (miRNA) than does the patient's benign pancreatic tissue or that found in other healthy pancreases. This paves the way for two possibilities:
- A more early but likely expensive genetic and biochemical molecular screening test profile, which would be an innovation in this cancer.
- A possible new, creative and more effective therapies based on the various microRNA levels. This opens an exciting new front in confronting a very deadly disease.
As a summary; tests that examine the pancreas are used to detect (find), diagnose, and stage pancreatic cancer as follow:
- Physical exam and history
- Tumor markers
- Chest x-ray
- CT scan (CAT scan)
- MRI (magnetic resonance imaging)
- PET scan (positron emission tomography scan)
- Endoscopic ultrasound (EUS): This procedure is also called endosonography.
- Laparoscopy
- Endoscopic retrograde cholangiopancreatography (ERCP)
- Percutaneous transhepatic cholangiography (PTC): This test is done only if ERCP cannot be done.
- Biopsy
References
- ↑ Bakkevold KE, Arnesjø B, Kambestad B (1992). "Carcinoma of the pancreas and papilla of Vater: presenting symptoms, signs, and diagnosis related to stage and tumour site. A prospective multicentre trial in 472 patients. Norwegian Pancreatic Cancer Trial". Scand. J. Gastroenterol. 27 (4): 317–25. doi:10.3109/00365529209000081. PMID 1589710.